Ignite Creation Date:
2025-12-24 @ 12:34 PM
Ignite Modification Date:
2026-01-04 @ 8:24 AM
Study NCT ID:
NCT03535961
Status:
COMPLETED
Last Update Posted:
2020-12-02
First Post:
2017-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
Sponsor:
Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-10
First Submit QC Date:
None
Study First Post Date:
2018-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-01
Last Update Post Date:
2020-12-02
Last Update Post Date Type:
ACTUAL